Involvement of different calcium channels in the depolarization-evoked release of noradrenaline from sympathetic neurones in rabbit carotid artery

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 2, 2005, Pages 109-114

  Uhrenholt, Torben R ^a   Nedergaard, Ove A ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL T TYPE; MIBEFRADIL; NIMODIPINE; NORADRENALIN; OMEGA AGATOXIN; OMEGA CONOTOXIN;

ANIMAL TISSUE; CAROTID ARTERY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INHIBITION; ELECTROSTIMULATION; EVOKED RESPONSE; FEMALE; LIQUID SCINTILLATION COUNTING; MALE; MEMBRANE DEPOLARIZATION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RABBIT; SCINTILLATION SPECTROMETRY; SYMPATHETIC NERVE CELL;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CAROTID ARTERIES; DRUG INTERACTIONS; ELECTRIC STIMULATION; FEMALE; MALE; MIBEFRADIL; NEURONS; NOREPINEPHRINE; OMEGA-CONOTOXIN GVIA; RABBITS; SYMPATHETIC NERVOUS SYSTEM;

ORYCTOLAGUS CUNICULUS;

EID: 22544441595     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_90.x     Document Type: Conference Paper

References (35)

1. Bakx, A. L., E. E. van der Wall, S. Braun, H. Emanuelsson, A. V. Bruschke & I. Kobrin: Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exercise duration in patients with chronic stable angina pectoris: a multicenter, placebo-controlled study. Ro 40-5967 International Study Group. Amer. Heart J. 1995, 130, 748-757.
2. 2+ channel antagonist mibefradil (Ro 40-5967). Mol. Pharmacol. 1995, 48, 540-549.
3. Bowersox, S. S., T. Singh, L. Nadasdi, Z. Zukowska-Grojec, K. Valentino & B. B. Hoffman: Cardiovascular effects of ω-conopeptides in conscious rats: mechanisms of action. J. Cardiovasc. Pharmacol. 1992, 20, 756-764.
4. Catterall, W. A., J. Striessnig, T. P. Snutch & E. Perez-Reyes: International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacol. Rev. 2003, 55, 579-581.
5. Clasbrummel, B., H. Osswald & P. Illes: Inhibition of noradrenaline release by ω-conotoxin GVIA in the rat tail artery. Brit. J. Pharmacol. 1989, 98, 101-110.
6. Clozel, J.-R, W. Osterrieder, C. H. Kleinbloesem, H. A. Welker, B. Schläppi, R. Tudor, F. Heffi, R. Schmitt & H. Eggers: Ro 40-5967: a new nondihydropyridine calcium antagonist. Cardiovasc. Drug Rev. 1991, 9, 4-17.
7. Cunnane, T. C. & T. J. Searl: Neurotransmitter release mechanisms in autonomic nerve terminals. Adv. Second Messenger Phosphoprotein Res. 1994, 29, 425-459.
8. De Luca, A., C. G. Li, M. J. Rand, J. J. Reid, P. Thaina & H. K. Wong-Dusting: Effects of ω-conotoxin GVIA on autonomic neuroeffector transmission in various tissues. Brit. J. Pharmacol. 1990, 101, 437-447.
9. 2+ channels in mammalian central neurones. Trends Neurosci. 1995, 18, 89-98.
10. Göthert, M. & G. J. Molderings: Mibefradil- and ω-conotoxin GVIA-induced inhibition of noradrenaline release from the sympathetic nerves of the human heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 356, 860-863.
11. Martin, R. L., J. H. Lee, L. L. Cribbs, E. Perez-Reyes & D. A. Hanck: Mibefradil block of cloned T-type calcium channels. J. Pharmacol. Exp. Therap. 2000, 295, 302-308.
12. McCleskey, E. W., A. P. Fox, D. H. Feldman, L. J. Cruz, B. M. Olivera, R. W. Tsien & D. Yoshikami: ω-Conotoxin: direct and persistent blockade of specific types of calcium channels in neurones but not muscle. Proc. Natl. Acad. Sci. USA 1987, 84, 4327-4331.
13. Miljanich, G. P. & J. Ramachandran: Antagonists of neuronal calcium channels: structure, function, and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 707-734.
14. 2+ channels by Ro 40-5967. Circ. Res. 1994, 75, 144-148.
15. Molderings, G. J., J. Likungu & M. Göthert: N-Type calcium channels control sympathetic neurotransmission in human heart atrium. Circulation 2000, 101, 403-407.
16. 2+ channels in the terminal mesenteric artery of guinea pig. Circ. Res. 1999, 85, 596-605.
17. Morita, H., J. Shi, Y. Ito & R. Inoue: T-channel-like pharmacological properties of high voltage-activated, nifedipine-insensitive Ca2+ currents in the rat terminal mesenteric artery. Brit. J. Pharmacol. 2002, 137, 467-476.
18. Nap, A., M. J. Mathy, J. C. Bait, M. Pfaffendorf & P. A. van Zwieten: The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists. Fundam. Clin. Pharmacol. 2004, 18, 309-319.
19. Nedergaard, O. A.: Effect of ω-conotoxin GVIA on noradrenaline release from postganglionic sympathetic neurones in rabbit aorta. Pharmacology & Toxicology 2000, 86, 30-35.
20. Perney, T. M., L. D. Hirning, S. E. Leeman & R. J. Miller: Multiple calcium channels mediate neurotransmitter release from peripheral neurones. Proc. Natl. Acad. Sci. USA 1986, 83, 6656-6659.
21. Plummer, M. R., D. E. Logothetis & P. Hess: Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurones. Neuron 1989, 2, 1453-1463.
22. Pruneau, D. & J. A. Angus: ω-Conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Brit. J. Pharmacol. 1990, 100, 180-184.
23. 2+ channel currents in rat cerebellar granule neurones. J. Neurosci. 1995, 15, 2995-3012.
24. Smith, A. B. & T. C. Cunnane: ω-Conotoxin GVIA-resistant neuro-transmitter release in postganglionic sympathetic nerve terminals. Neuroscience 1996, 70, 817-824.
25. Smith, A. B. & T. C. Cunnane: Multiple calcium channels control neurotransmitter release from rat postganglionic sympathetic nerve terminals. J. Physiol. 1997, 499, 341-349.
26. Tanaka, Y., Y. Mochizuki, H. Taneka & K. Shigenobu: Significant role of neuronal non-N-type calcium channels in the sympathetic neurogenic contraction of rat mesenteric artery. Brit. J. Pharmacol. 1999, 128, 1602-1608.
27. Tareilus, E. & H. Breer: Presynaptic calcium channels: pharmacology and regulation. Neurochem. Int. 1995, 26, 539-558.
28. Tsien, R. W., D. Lipscombe, D. V. Madison, K. R. Bley & A. P. Fox AP: Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 1988, 11, 431-438.
29. Uhrenholt, T. R. & O. A. Nedergaard: Calcium channels involved in noradrenaline release from sympathetic neurones in rabbit carotid artery. Proc. West. Pharmacol. Soc. 2001, 44, 224-225.
30. Uhrenholt, T. R. & O. A. Nedergaard: Action of mibefradil on vascular sympathetic neuroeffector transmission. The Pharmacologist 2002, 44, (Suppl 1), A624.
31. Uhrenholt, T. R. & O. A. Nedergaard: Calcium channels involved in noradrenaline release from sympathetic neurones in rabbit carotid artery. Pharmacology & Toxicology 2003, 92, 226-233.
32. van der Lee, R., M. Pfaffendorf, J. G. De Mey & P.A. van Zwieten: Inhibitory effect of mibefradil on contractions induced by sympathetic neurotransmitter release in the rat tail artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 2000, 361, 74-79.
33. Watermann S. A.: Role of N-, P- and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens. Brit. J. Pharmacol. 1997, 120, 393-398.
34. Xi, Q. & J. A. Angus: Evidence against an action of mibefradil at N-type voltage-operated calcium channels. Naunyn-Schmiedeberg's Arch. Pharmacol. 2001, 364, 430-436.
35. Xi, Q., J. Ziogas, J. A. Roberts, R. J. Evans & J. A. Angus: Involvement of T-type calcium channels in excitatory junction potentials in rat resistance mesenteric arteries. Brit. J. Pharmacol. 2002, 137, 805-812.